Cargando…

The pooled prevalence of pulmonary embolism in patients with COVID-19

Detalles Bibliográficos
Autores principales:	Shi, Li, Xu, Jie, Duan, Guangcai, Yang, Haiyan, Wang, Yadong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489453/ https://www.ncbi.nlm.nih.gov/pubmed/32929580 http://dx.doi.org/10.1007/s00134-020-06235-8

Ejemplares similares

Pooled prevalence of deep vein thrombosis among coronavirus disease 2019 patients
por: Wang, Ying, et al.
Publicado: (2020)

Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19
por: Shi, Li, et al.
Publicado: (2020)

NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis
por: Wang, Ying, et al.
Publicado: (2023)

Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients
por: Wang, Ying, et al.
Publicado: (2020)

Prevalence of Pulmonary Embolism in COVID-19: a Pooled Analysis
por: Desai, Rupak, et al.
Publicado: (2020)

Impact of non-pharmaceutical interventions during COVID-19 pandemic on measles and mumps in Mainland China()()()()
por: Xu, Jie, et al.
Publicado: (2023)

The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates
por: Liang, Xuan, et al.
Publicado: (2020)

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
por: Scudiero, Fernando, et al.
Publicado: (2021)

Meta-Analysis of Relation of Creatine kinase-MB to Risk of Mortality in Coronavirus Disease 2019 Patients
por: Shi, Li, et al.
Publicado: (2020)

Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates
por: Yang, Haiyan, et al.
Publicado: (2021)

Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates
por: Yang, Haiyan, et al.
Publicado: (2021)

The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates
por: Li, Shuwen, et al.
Publicado: (2022)

The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates
por: Yang, Haiyan, et al.
Publicado: (2021)

COVID-19 and Acute Pulmonary Embolism in Postpartum Patient
por: Khodamoradi, Zohre, et al.
Publicado: (2020)

HER3 over-expression and overall survival in gastrointestinal cancers
por: Wang, Yadong, et al.
Publicado: (2015)

Cerebrovascular disease is associated with the risk of mortality in coronavirus disease 2019
por: Wang, Ying, et al.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 disease
por: Kalemci, Serdar, et al.
Publicado: (2020)

Pulmonary embolism detected by CT pulmonary angiography in hospitalized COVID-19 patients
por: Bunel, V., et al.
Publicado: (2021)

Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19?
por: Páramo, José A.
Publicado: (2020)

Lack of significant association between dyslipidemia and COVID-19 mortality
por: Yang, Haiyan, et al.
Publicado: (2021)

Bilateral Pulmonary Embolism and Impending Paradoxical Embolism After COVID-19 Vaccination
por: Grant, Stuart W., et al.
Publicado: (2023)

Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis
por: Shi, Li, et al.
Publicado: (2021)

Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis
por: Han, Xueya, et al.
Publicado: (2022)

The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis
por: Wang, Yadong, et al.
Publicado: (2016)

Genome mining reveals the prevalence and extensive diversity of toxin–antitoxin systems in Staphylococcus aureus
por: Xu, Jie, et al.
Publicado: (2023)

Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!
por: Sanfilippo, F., et al.
Publicado: (2020)

Acute pulmonary embolism: An unseen villain in COVID-19
por: Agstam, Sourabh, et al.
Publicado: (2020)

Characteristics and outcomes of COVID-19-associated pulmonary embolism
por: Sedhom, Ramy, et al.
Publicado: (2023)

Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer
por: Rodriguez-Sevilla, Juan José, et al.
Publicado: (2020)

Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer
por: Rodriguez-Sevilla, Juan José, et al.
Publicado: (2020)

Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19
por: Zuin, Marco, et al.
Publicado: (2022)

Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia
por: Le Berre, A., et al.
Publicado: (2020)

Pulmonary embolism among critically ill patients with ARDS due to COVID-19
por: Soumagne, T., et al.
Publicado: (2020)

Pulmonary embolism and acro-ischemia in a lung cancer patient with COVID-19
por: González del Portillo, Elisabet, et al.
Publicado: (2020)

Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?
por: Roncon, Loris, et al.
Publicado: (2020)

Severe pulmonary embolism in COVID-19 patients: a call for increased awareness
por: Hékimian, Guillaume, et al.
Publicado: (2020)

Characteristics and predictors of pulmonary embolism in patients admitted for COVID-19 with respiratory failure
por: Fraccalini, Thomas, et al.
Publicado: (2022)

Does COVID-19 vaccination protect against pulmonary embolism?
por: Tantillo, Simona, et al.
Publicado: (2023)

Three-month follow-up of pulmonary embolism in patients with COVID-19
por: Whyte, Martin B., et al.
Publicado: (2021)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5vf4h50t62buc9sf80gv19nc6v